Used as an intermediate in organic synthesis, particularly in the preparation of pharmaceutical compounds and bioactive molecules. Its structure allows for selective functionalization, making it valuable in the development of drug candidates, especially those targeting central nervous system disorders. The bromine moiety serves as a reactive site for further chemical modifications, such as nucleophilic substitution or cross-coupling reactions, enabling the introduction of various side chains. It is also employed in the synthesis of proteolysis-targeting chimeras (PROTACs) and other bifunctional molecules where controlled linker length and reactivity are essential.